A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
The Kappa Opioid Receptor | SpringerLink
Opioid-based plant might not be best solution for those seeking to curb habitual alcohol use - Purdue University News
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Pathways and Receptors – Opioid Peptides
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
IJMS | Free Full-Text | The Mechanisms Involved in Morphine Addiction: An Overview
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
Kappa Opioid System in Nucleus Accumbens Drives Pain-Induced Negative Affect | Pain Research Forum
κ-opioid receptor - Wikipedia
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain